GlassScriptPhysician profile
Aaron Sanders
NPI 1821452277
$2,498.88
in general payments reported to CMS, 2019-2025
16 companies · $65.49 in 2025
The $65.49 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.33 · 2021: $1,596 · 2022: $514 · 2023: $142 · 2024: $133 · 2025: $65.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,029.63 | 2021 | |
| Nevro Corp. | $491.12 | 2021-2024 | Senza |
| Spr Therapeutics, INC | $299.22 | 2022-2024 | Sprint Pns System |
| Boston Scientific Corporation | $171.71 | 2020-2021 | |
| Medtronic, INC. | $137.03 | 2022-2023 | Accurian |
| Abbvie INC. | $97.49 | 2021 | |
| Mindray Ds USA, INC. | $52.08 | 2023 | Na Electrode,Indirect,International, Patient Monitor |
| Scilex Pharmaceuticals INC. | $48.34 | 2024 | |
| Baxter Healthcare | $31.10 | 2023 | Floseal |
| Globus Medical, INC. | $24.31 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.25 | 2025 | Relistor |
| Nalu Medical, INC. | $20.34 | 2022 | |
| Redhill Biopharma INC. | $20.20 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.93 | 2025 | |
| Averitas Pharma INC. | $18.95 | 2023 | Qutenza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $16.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.